Angiotensin converting enzyme gene insertion/deletion polymorphism in patients with polycystic ovary syndrome

Gynecological Endocrinology

Volumn 26, Issue 6, 2010, Pages 393-398

  Karabulut, Aysun ^a   Turgut, Sebahat ^b   Turgut, Günfer ^b  

^a DENIZLI STATE HOSPITAL   (Turkey)

^b PAMUKKALE UNIVERSITY   (Turkey)

Author keywords

Angiotensin converting enzyme gene; Insulin resistance; Ovary; Polycystic ovary syndrome; Polymorphism

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; GLUCOSE; INSULIN; TESTOSTERONE;

ADULT; ALLELE; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENETIC POLYMORPHISM; GENOTYPE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; OVARY POLYCYSTIC DISEASE; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TESTOSTERONE BLOOD LEVEL;

ADULT; FEMALE; HUMANS; INSULIN RESISTANCE; PEPTIDYL-DIPEPTIDASE A; POLYCYSTIC OVARY SYNDROME; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 77952193034     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513591003632167     Document Type: Article

References (33)

1. Solomon CG. The epidemiology of polycystic ovary syndrome. Prevalence and associated disease risks. Endocrinol Metab Clin North Am 1999;28:247-263.
2. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19-25.
3. Legro RS, Strauss JF. Molecular progress in infertility: polycystic ovary syndrome. Fertil Steril 2002;78:569-576.
4. Luque-Ramírez M, San Millán JL, Escobar-Morreale HF. Genomic variants in polycystic ovary syndrome. Clin Chim Acta 2006;366:14-26.
5. Dunaif A. Hyperandrogenic anovulation (PCOS): a unique disorder of insulin action associated with an increased risk of non-insulin dependent diabetes mellitus. Am J Med 1995;98: 33S-39S.
6. Ehrmann DA, Barnes RB, Rosenfield RL, Cavaghan MK, Imperial J. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 1999;22:141-146.
7. Legro RS, Kunselman AR, Dodson WC, Dunaif A. Prevalence and predictors of risk for type two diabetes mellitus and impaired glucose tolerance in polycystic ovarian syndrome: a prospective randomized study in 254 affected women. J Clin Endocrinol Metab 1999;84:165-169.
8. Caliskan E, Kilic T, Bodur H, Zeteroglu S. The frequency of metabolic syndrome in women with polycystic ovaries at reproductive ages and comparison of different metabolic syndrome diagnostic criteria. J Turkish German Gynecol Assoc 2007;8:402-407.
9. Reaven GM. Insulin resistance, hyperinsulinemia, hypertriglyceridemia and hypertension. Parallels between human disease and rodent models. Diabetes Care 1991;14:195-202.
10. Zavaroni I, Bonora E, Pagliara M, Dall'Aglio E, Luchetti L, Buonanno G, Bonatti PA, Bergonzani M, Gnudi L, Passeri M, et al. Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med 1989;320:702-706.
11. Kelly CCJ, Lyall H, Petrie JR, Gould GW, Connell JMC, Dattar N. Low grade chronic inflammation in women with polycystic ovarian syndrome. J Clin Endocrinol Metab 2001; 86:2453-2455.
12. Schacter M, Raziel A, Friedler S, Starssburger D, Bern O, Ron-El R. Insulin resistance in patients with polycystic ovary syndrome is associated with elevated plasma homocysteine. Hum Reprod 2003;8:721-727.
13. Oktem M, Ozcimen EE, Uckuyu A, Esinler I, Pamuk B, Bayraktar N, Kulaksizoglu S, Zeyneloglu HB. CD40 ligand, a marker of coronary artery disease: Fertil Steril 2008;91:2545-2550.
14. Yoshimuro Y. The ovarian renin-angiotensin system in reproductive physiology. Front Neuroendocrinol 1997;18: 247-291.
15. Hefler LA, Gregg AR. Influence of angiotensinogen gene on the ovulatory capacity of mice. Fertil Steril 2001;75:1206-1211.
16. van Sande ME, Scharpé SL, Neels HM, Van Camp KO. Distribution of angiotensin converting enzyme in human tissues. Clin Chim Acta 1985;147:255-260.
17. Plendl J, Neumiiller C, Vollmar A, Auerbach R, Sinowatz F. Isolation and characterization of endothelial cells from different organs of fetal pigs. Anat Embryol 1996;194:445-456.
18. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion deletion polymorphism in angiotensin-I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990;86:1343-1346.
19. Alvarez R, Terrados N, Ortolono R, Iglesias-Cubera G, Cortina A, Alvarez V, Cto E. Genetic variation in the renin-angiotensin system and athletic performance. Eur J Appl Physiol 2000;82:117-120.
20. Turgut G, Turgut S, Genc O, Atalay A, Atalay EO. The angiotensin converting enzyme I/D polymorphism in Turkish athletes and sedentary controls. Acta Medica 2004;47:133-136.
21. Dursunoglu D, Tanriverdi H, Turgut S, Evrengul H, Turgut G, Kilic M. Do left ventricular mass, diameters and long-axis systolic function differ according to angiotensin converting enzyme genotypes? Anadolu Kardiyol Derg 2005;5:172-177.
22. Matthews DR, Connolly AA, Holman RR, Turner RC. Physiology of insulin secretion: problems of quantity and timing. Neth J Med 1985;28:20-24.
23. Russ AP, Maerz W, Ruzicka V, Stein U, Gross W. Rapid detection of the hypertension-associated Met235-Thr allele of the human angiotensinogen gene. Hum Mol Genet 1993;2:609-610.
24. Carmina E, Napoli N, Longo RA, Rini GB, Lobo RA. Metabolic syndrome in polycystic ovary syndrome (PCOS): lower prevalence in southern Italy than in the USA and the influence of criteria for the diagnosis of PCOS. Eur J Endocrinol 2006;154:141-145.
25. Soares EMM, Azevedo GD, Gadelha RGN, Moura Lemos TMA, Maranhao TMO. Prevalence of the metabolic syndrome and its components in Brazilian women with polycystic ovary syndrome. Fertil Steril 2008;89:649-655.
26. Legro RS, Gnatuk CL, Kunselman AR, Dunaif A. Changes in glucose tolerance over time in women with polycystic ovary syndrome: a controlled study. J Clin Endocrinol Metab 2005; 90:3236-3242.
27. Sun J, Fan H, Che Y, Cao Y, Wu X, Sun HX, Liang F, Yi L, Wang Y. Association between ACE gene I/D polymorphisms and hyperandrogenism in women with polycystic ovary syndrome (PCOS) and controls. BMC Med Genet 2009; 10:64.
28. Akin F, Turgut S, Dursunoglu D, Turgut G, Karasu U, Gur S. ACE gene polymorphism and cardiac structure in patients with insulin resistance. Mol Biol Rep 2009;36:623-629.
29. Panahloo A, Andrès C, Mohamed-Ali V, Gould MM, Talmud P, Humphries SE, Yudkin JS. The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Circulation 1995;92:3390-3393.
30. Thamer C, Koch M, Haap M, Machicao F, Häring HU, Stumvoll M. Association of the ACE gene I/D polymorphism with insulin sensitivity depends on the presence of additional macroangiopathic risk factors. Atherosclerosis 2002;160:257-258.
31. Genazzani AD, Lanzoni C, Ricchieri F, Baraldi E, Casarosa E, Jasonni VM. Metformin administration is more effective when non-obese patients with polycystic ovary syndrome show both hyperandrogenism and hyperinsulinemia. Gynecol Endocrinol 2007;23:146-152.
32. Alexander CJ, Tangchitnob EP, Lepor NE. Polycystic ovary syndrome: a major unrecognized cardiovascular risk factor in women. Rev Cardiovasc Med 2009;10:83-90.
33. Zintzaras E, Raman G, Kitsios G, Lau J. Angiotensinconverting enzyme insertion/deletion gene polymorphic variant as a marker of coronary artery disease: a meta-analysis. Arch Intern Med 2008;168:1077-1089.